Medical Cost Offsets from Prescription Drug Utilization Among Medicare Beneficiaries

被引:10
|
作者
Roebuck, M. Christopher [1 ]
机构
[1] RxEcon LLC, Hunt Valley, MD USA
来源
关键词
D O I
10.18553/jmcp.2014.20.10.994
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This brief commentary extends earlier work on the value of adherence to derive medical cost offset estimates from prescription drug utilization. Among seniors with chronic vascular disease, 1% increases in condition specific medication use were associated with significant (P<0.001) reductions in gross nonpharmacy medical costs in the amounts of 0.63% for dyslipidemia, 0.77% for congestive heart failure, 0.83% for diabetes, and 1.17% for hypertension. Copyright (C) 2014, Academy of Managed Care Pharmacy. All rights reserved.
引用
下载
收藏
页码:994 / 995
页数:2
相关论文
共 50 条
  • [21] Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure
    McGee, Blake Tyler
    Phillips, Victoria
    Higgins, Melinda K.
    Butler, Javed
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (06): : 705 - 713
  • [22] Prescription drug spending among medicare beneficiaries with chronic conditions: Trends and issues
    Boccuti, C
    Moon, M
    Dowling, K
    GERONTOLOGIST, 2003, 43 : 285 - 286
  • [23] Prescription Opioid Utilization Among Medicare Beneficiaries with and without Recent Substance Abuse Disorder
    Kuzucan, Aida
    Simoni-Wastila, Linda
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 630 - 631
  • [24] Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10US States
    Moyo, Patience
    Simoni-Wastila, Linda
    Griffin, Beth Ann
    Onukwugha, Eberechukwu
    Harrington, Donna
    Alexander, G. Caleb
    Palumbo, Francis
    ADDICTION, 2017, 112 (10) : 1784 - 1796
  • [25] Estimating the effects of prescription drug coverage for medicare beneficiaries
    Shea, Dennis G.
    Terza, Joseph V.
    Stuart, Bruce C.
    Briesacher, Becky
    HEALTH SERVICES RESEARCH, 2007, 42 (03) : 933 - 949
  • [26] Utilization and cost of anti-osteoporosis therapy among US Medicare beneficiaries
    Smita Jha
    Timothy Bhattacharyya
    Archives of Osteoporosis, 2016, 11
  • [27] UTILIZATION AND COST OF DIABETIC MEDICATIONS AMONG US MEDICARE PART D BENEFICIARIES
    Zhao, J.
    Carlson, A. M.
    VALUE IN HEALTH, 2017, 20 (05) : A177 - A177
  • [28] Utilization and cost of anti-osteoporosis therapy among US Medicare beneficiaries
    Jha, Smita
    Bhattacharyya, Timothy
    ARCHIVES OF OSTEOPOROSIS, 2016, 11 (01)
  • [29] Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit
    Goedken, Amber M.
    Urmie, Julie M.
    Farris, Karen B.
    Doucette, William R.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (01) : 18 - U12
  • [30] Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries
    Lewis, JH
    Schonlau, M
    Muñoz, JA
    Asch, SM
    Rosen, MR
    Yang, H
    Escarce, JJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11): : 830 - 835